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Latrophilins (LPHNs) are adhesion-like G-protein-
coupled receptors implicated in attention-deficit/
hyperactivity disorder. Recently, LPHN3 was found
to regulate excitatory synapse number through trans
interactions with fibronectin leucine-rich repeat
transmembrane 3 (FLRT3). By isothermal titration
calorimetry, we determined that only the olfactome-
din (OLF) domain of LPHN3 is necessary for FLRT3
association. By multi-crystal native single-wave-
length anomalous diffraction phasing, we deter-
mined the crystal structure of the OLF domain. This
structure is a five-bladed b propeller with a Ca2+ ion
bound in the central pore, which is capped by a
mobile loop that allows the ion to exchange with
the solvent. The crystal structure of the OLF/FLRT3
complex shows that LPHN3-OLF in the closed state
binds with high affinity to the concave face of
FLRT3-LRR with a combination of hydrophobic and
charged residues. Our study provides structural
and functional insights into the molecular mecha-
nism underlying the contribution of LPHN3/FLRT3
to the development of glutamatergic synapses.
INTRODUCTION
Latrophilins (LPHNs) are adhesion G-protein-coupled receptors
(adhesion GPCRs), the second largest class of GPCRs (Sudhof,
2001). LPHNs consists of three isoforms, LPHN1–3, expressed
largely in the CNS (Ichtchenko et al., 1999). Common variants
of the LPHN3 gene confer susceptibility to attention-deficit/hy-
peractivity disorder (ADHD) (Arcos-Burgos et al., 2010), predict
effectiveness of stimulant medication (Labbe et al., 2012), and
affect behavioral and neurophysiological measures of cognitive
response control (Fallgatter et al., 2013). A single point mutationStructure 23, 1665–16in human LPHN3 was found in an ADHD patient (Domene et al.,
2011). This mutation is in the olfactomedin domain (Ala247Ser,
corresponding to mouse Ala313Ser), but the biological effects
of this mutation are currently unknown.
Structurally, LPHNs are characterized by a seven-transmem-
brane region and a large N-terminal extracellular sequence
containing the following domains: a rhamnose-binding lectin
(RBL) domain; an olfactomedin (OLF)-like domain followed by
a serine/threonine-rich domain that is O-linked glycosylated
(O’Sullivan et al., 2014); a hormone-binding (HR) domain; and a
GPCR autoproteolysis-inducing (GAIN) domain (Figure 1A). We
recently reported that LPHN3 binds in vivo and in vitro to fibro-
nectin leucine-rich repeat transmembrane 3 (FLRT3) to consti-
tute a synaptic ligand-receptor pair that can modulate excitatory
synapse number (O’Sullivan et al., 2012). There are three FLRT
genes, FLRT1–3, encoding single-pass transmembrane proteins
with one extracellular leucine-rich repeat (LRR) domain and a
juxtamembrane fibronectin type 3 (FNIII) module (Lacy et al.,
1999). Synaptic puncta density and cell-based binding experi-
ments using deletion of the OLF or the OLF-RBL domains pre-
vented rescue of the synaptic phenotype, and suggested that
whereas the OLF domain is required for interaction with FLRTs,
both the RBL and OLF domains are involved in the interaction
with teneurin 1 (TEN1), a cell surface protein involved in brain
development. These data indicate that the extracellular domain
of LPHN3 contains a distal ligand binding module situated on
an elongated and potentially flexible stalk long enough to span
the synaptic cleft, with differentiable FLRT3 and TEN1 binding
sites (O’Sullivan et al., 2014).
OLFs were first discovered in the frog olfactory neuroepithe-
lium (Snyder et al., 1991). The OLF domain has a length of about
250 amino acids and is present in at least 13 proteins in mam-
mals (Tomarev and Nakaya, 2009). A growing body of evidence
indicates that these proteins play important roles in normal
development and disease in mammals, and mutations in some
of these genes lead to profound disorders in humans (Anholt,
2014). The most extensively studied OLF-containing protein is
probably myocilin, in which mutations are found in more than
10% of juvenile open-angle glaucoma cases and in 3%–4% of77, September 1, 2015 ª2015 Elsevier Ltd All rights reserved 1665
Figure 1. Characterization of LPHN3-OLF
and FLRT3-LRR in Solution
(A) Schematic representation of LPHN3 and FLRT3
domain architecture. N and C designate N and C
termini of the proteins. Dotted lines indicate
constructs that did not bind, solid lines indicate
constructs that bind, and solid lines with terminal
diamonds indicate constructs used in (B).
(B) ITC of LPHN3-OLF injected at 100 mM into the
cell containing the FLRT3-LRR domain at 10 mM.
(C) SEC of the purified LPHN3-OLF, FLRT3-LRR,
and their complex using a Superdex 200-10/300 Gl
column. Top margin shows the column calibration.
As expected for 1:1 stoichiometry, OLF eluted
with an apparent molecular weight of 30 kDa;
LRR,  71 kDa; and the complex, 90 kDa. Inset:
Coomassie blue staining SDS-PAGE of the purified
proteins.
(D) Sedimentation velocity of LPHN3-OLF,
FLRT3-LRR, and their complex, at two concen-
trations. Overlay of the diffusion-corrected inte-
gral sedimentation coefficient distributions from
the van Holde-Weischet analysis shows a
single species with homogeneous distribution for
LPHN3-OLF and the complex but significant
self-association for FLRT-LRR. The frictional
ratio of the monomer suggested a slightly non-
globular shape and was determined to be 1.53
(1.48 and 1.58 with 95% confidence intervals). The
dimer frictional ratio was found to be more elon-
gated, at 1.76 (1.74 and 1.78 with 95% confidence
intervals).
(E) The van Holde-Weischet analysis of the FLRT3-
LRR concentrations reveals two distinct but over-
lapping species, indicating a clear monomer-dimer
equilibrium.patients with adult-onset primary open-angle glaucoma (Fingert
et al., 1999; Stone et al., 1997). The available crystal structures of
gliomedin andmyocilin, twomembers of the OLF family, reveal a
five-blade b-propeller fold and the presence of Ca2+ and/or Na+
in the central pore (Donegan et al., 2014; Han and Kursula, 2015).
Recent findings on the extracellular domain of FLRT3 reveal that
this protein has the tendency to homodimerize, but a precise
characterization of dimerization potential is currently unknown.
Moreover, the study of FLRT2-LRR, alone and in complex with
the cell surface receptor uncoordinated-5 D (UNC5D), revealed
that FLRT2-UNC5D interaction controls neuronal radial migra-
tion whereas FLRT-FLRT interactionmodulates spatial organiza-
tion in the tangential axis (Seiradake et al., 2014). Subsequently,
the same group solved the crystal structure of mouse LPHN3
lectin and olfactomedin-like domains, confirming that the OLF
domain is a five-bladed b propeller containing Ca2+ and Na+
binding sites (Jackson et al., 2015).1666 Structure 23, 1665–1677, September 1, 2015 ª2015 Elsevier Ltd All rights reservedHere, we present the solution charac-
terization of mouse LPHN3-OLF, FLRT3-
LRR, the crystal structure of LPHN3-OLF
alone in two different conformations, its
complex with the LRR domain of FLRT3,
and a characterization of the association
including the effect of the Ser247Ala hu-
man mutation. Our structural analysissuggests that the high-affinity interaction between LPHN3-OLF
and FLRT3 is necessary for some aspects of the development
of glutamatergic synapses.
RESULTS
Isothermal Titration Calorimetry Characterization of
LPHN3 and FLRT3 Interactions
To determine which domain of FLRT3 and LPHN3 is directly
involved in the association, we engineered different constructs
for each protein (Figure 1A). The extracellular domain of
LPHN3 was divided into three portions: the N-terminal half
including the RBL, OLF, and theO-linked carbohydrate domains,
the OLF domain alone, and the C-terminal half containing the
HR-GAIN-GPS domains. The extracellular domain of FLRT3
was also split into two constructs, one containing the FN3
domain alone (FLRT3-FN3) and the other containing the ten
Table 1. ITC Binding Experiments Using Various LPHN3 and
FLRT3 Constructs
Deletion Constructs of LPHN3 and FLRT3
KD (nM) LPHN3 GAIN-HR OLF-RBL OLF
FLRT3 31 ± 7.9 No binding 43.3 ± 13.8 ND
FN3 No binding ND ND ND
LRR ND ND 34.2 ± 7.5 16.9 ± 15.9
Amino Acid Substitutions in LPHN3-OLF and FLRT3-LRR
KD (nM) LPHN3-OLF LPHN3-OLF
D332A
LPHN3-OLF
Y323A
LPHN3-OLF
A313S
FLRT3-LRR 17 170 No binding 19
FLRT3-LRR
R117T
27 ND ND ND
FLRT3-LRR
F160N
No binding ND ND ND
FLRT3-LRR
F160A
1,000 ND ND ND
For each pair, at least three experiments were recorded. ND, not
determined.LRR repeats between amino acids 29 and 386 (FLRT3-LRR).
Isothermal titration calorimetry (ITC) experiments were per-
formed to assess which construct retained the affinity of the
full extracellular domain. Our data show that binding occurred
between FLRT3-LRR and LPHN3-OLF (LPHN3 amino acids
199–495) (Figure 1B; Table 1) with an affinity similar to the one
previously reported for the full-length extracellular domains
(O’Sullivan et al., 2012). Because no association was recorded
using either the LPHN3-HR-GAIN-GPS construct or FLRT3-
FN3 domains, we conclude that LPHN3-OLF and FLRT3-LRR
represent the complete binding cassette of these proteins. ITC
experiments in the presence of 1 mM EDTA or 2 mM Ca2+
showed that the binding affinity remains unchanged (data not
shown), indicating that the interaction does not require Ca2+ at
the interface, as is the case for neuroligin/neurexin interaction
(Fabrichny et al., 2007). The interaction data were interpreted us-
ing single-site model fitting indicating that, under our conditions,
the tendency of FLRT3-LRR to dimerize (see below) was abol-
ished by the LPHN3-OLF/FLRT3-LRR association.
Solution Characterization of the Protein Samples
Size-Exclusion Chromatography
The purified LPHN3-OLF domain, FLRT3-LRR, and their com-
plex were analyzed by size-exclusion chromatography (SEC)
to ensure sample monodispersity for subsequent biophysical
experiments and to help interpretation of the crystallography
packing data. LPHN3-OLF and the OLF-LRR complex eluted
as single peaks, indicating ideal monodispersity and apparent
molecular weights consistent with their monomeric forms (Fig-
ure 1C). However, the elution profile of LRR alone appears larger
than expected, consistent with the fact that FLRT3-LRR un-
dergoes a concentration-dependent oligomerization due to a
low-affinity homophilic interaction of the LRR domain of FLRT3
(Seiradake et al., 2014).
Analytical Ultracentrifugation
To obtain more quantitative data in solution on the oligomeriza-
tion state of our samples, we performed sedimentation velocityStructure 23, 1665–16experiments (SV) at two loading concentrations (0.3 and 0.9
OD280). Diffusion-corrected van Holde-Weischet sedimentation
coefficient distributions of LPHN3-OLF and the OLF-LRR com-
plex indicated single homogeneous species that did not change
sedimentation distribution as a function of loading concentration
(4.1 and 13.5 mM for LPHN3-OLF, and 2.4 and 7.5 mM for
the OLF-LRR complex) (Figure 1D). These data indicate that
LPHN3-OLF is a monomer with an estimated molecular weight
of 37,195 Da and 37,340 Da for the low and high concentrations,
respectively, in line with the 36.6-kDa value calculated from the
sequence of our expressed protein. The OLF-LRR complex ex-
ists as a 1:1 assembly with an estimated molecular weight of
95 kDa, a value compatible with the mass of the glycosylated
complex (81.9 kDa). To characterize the apparent dimerization
of FLRT3-LRR, samples weremeasured by analytical ultracentri-
fugation (AUC) at two loading concentrations—0.38 and 0.92
OD280—corresponding to 7.6 and 18.3 mM, respectively. The
van Holde-Weischet analysis shows a strong mass action effect
with amarked shift to a higher sedimentation coefficient distribu-
tion for the higher concentration (Figure 1E). Subsequently, to
calculate the dissociation constant (KD) for the monomer-dimer
equilibrium, both concentrations were fitted with finite element
solutions of the Lamm equation that models the reversible inter-
action for a monomer-dimer system (Cao and Demeler, 2008;
Demeler et al., 2010). The fit resulted in virtually identical KD
values for both fits, averaging 43.3 mM (39.7–46.9 mM with
95% confidence intervals). Taken together, these data indicate
that when LPHN3-OLF associates with FLRT3-LRR, its weak
dimerization is converted in the formation of a 1:1 complex.
The LPHN3-OLF Crystal Structure
Under our experimental conditions, LPHN3-OLF crystallized in a
hexagonal (P65) or an orthorhombic (C2221) lattice. The structure
was solved by native single-wavelength anomalous diffraction
(SAD) phasing using the recently describedmulti-crystal phasing
procedure (Liu et al., 2012, 2014) with the P65 crystal form. The
resulting initial model was then used to position the LPHN3-
OLF in the C2221 lattice by molecular replacement, and both
structures were completed and refined using 1.6-A˚ high-resolu-
tion datasets (see Experimental Procedures; Table 2).
In both crystal forms, the crystallized LPHN3-OLF construct
polypeptidic chain was built in the respective electron density
maps except from its N-terminal (linker, FLAG tag, and Lys199)
and C-terminal (463–495 and the 3C protease residual recogni-
tion motif) fragments, as well as the loop 392–405, which could
not be entirely modeled due to the lack of reliable definition of
the position by the electron density maps for several residues
(i.e. fragments 395–403 and 397–403 absent in the C2221 and
the P65 form, respectively) (Table S1; Figure 2). Consistently,
these three fragments are shown to be among the highest sol-
vent-exposed portions of the protein by hydrogen-deuterium ex-
change coupled with mass spectrometry (DXMS) (see below).
The peptide 395-YEDDDNEAT-403 is most likely highly solvated
on the five negatively charged Asp and Glu residues clustered in
this small nine-residue fragment on the surface of the protein. As
for the N- and C-terminal fragments, they likely have undergone
cleavage during the crystallization process, as we found that the
form of the protein that provided suitable crystals was shorter
than the one present in freshly purified preparations used for77, September 1, 2015 ª2015 Elsevier Ltd All rights reserved 1667
Table 2. Crystallographic Data Statistics
LPHN3-OLF
Complex OLF/LRRNative SAD Phasing P65 form C2221 form
Data Collection
Beamline NSLS X4A NSLS X4C CHESS F1 CHESS F1
Energy (keV)/wavelength (A˚) 6.0/2.07 12.7/0.97 13.8/0.91 13.8/0.91
Space group P65 P65 C2221 P3121
Unit cell parameters
a, b, c (A˚) 84.1, 84.1, 66.1 85.1, 85.1, 66.1 78.8, 96.8, 79.2 121.9, 121.9, 84.0
a, b, g () 90.0, 90.0, 120.0 90.0, 90.0, 120.0 90.0, 90.0, 90.0 90.0, 90.0, 120.0
No. of crystals 2 1 1 1
Bragg spacings (A˚) 40–2.60 (2.67–2.60) 40–1.61 (1.65–1.61) 48.4–1.6 (1.63–1.60) 49.3–3.2 (3.41–3.19)
Rp.i.m.
a 0.009 (0.257) 0.018 (0.290) 0.027 (0.379) 0.055 (0.474)
<I/s(I)> 77.2 (2.2) 30.5 (3.1) 18.4 (1.9) 9.4 (1.5)
Completeness (%) 95.4 (60.4) 99.1 (96.6) 98.8 (86.9) 99.7 (99.0)
CC1/2 – 1.00 (0.76) 1.00 (0.66) 0.96 (0.91)
Multiplicity 92.9 (10.0) 22.6 (19.7) 6.6 (3.5) 1.9 (1.9)
Phasing
No. of sites 5 – – –
FOM (before/after density modification) 0.293/0.649 – – –
Refinement
Resolution (A˚) 2.6 1.6 1.6 3.2
R/Rfree
b (%) 14.5/21.5 16.5/19.0 17.7/19.6 25.7/33.7
B factors (A2)
Protein 31.5 21.0 21.6 153.9
Heteroatoms 30.6 25.8 26.1 226.9
Rmsd
Bond length (A˚) 0.009 0.007 0.007 0.009
Bond angles () 1.14 1.13 1.07 1.1
Ramachandran plot
Favored regions (%) 94.1 94.8 98.9 84.5
Outliers (%) 0 0 0 1.2
Values in parentheses are for highest-resolution shell. CC1/2, half dataset correlation coefficient; FOM, figure of merit.
aRp:i:m: =
P
hkl
ﬃﬃﬃﬃﬃ
1
n1
p Pn
j = 1
jIhkl;jhIhklijP
hkl
P
j
Ihkl;j
, where Ihkl,j is the intensity of the jth observation for unique hkl and hIhkli is the mean intensity for unique hkl.
bR=
P
jjFcalc jjFobs jjP
jFobs j , where Fobs and Fcalc are the observed and calculated structure factors, respectively; Rfree is calculated using a subset (10%) of the
data excluded from the refinement.AUC and DXMS (see Experimental Procedures). A disulfide bond
formed by Cys203 and Cys385 was found to be partially disrup-
ted, most likely due to radiation damage from the X-ray beam.
Our LPHN3-OLF structure is very similar to several other OLF
domain structures recently determined from LPHN3 (the mouse
LPHN3 lectin and OLF-like domains [LPHN3-RBL/OLF]) (Jack-
son et al., 2015), gliomedin (gliomedin-OLF) (Han and Kursula,
2015), myocilin (myocilin-OLF) (Donegan et al., 2014) and noelin
(noelin-OLF) (Pronker et al., 2015) (Table S2; Figure 2). Consis-
tently, our LPHN3-OLF structure displays a five-bladed b-pro-
peller folding, i.e. 20 b strands arranged in five four-stranded,
highly twisted, anti-parallel b sheets (blades) (Figure 2A). The
blades are organized around a central conical pore ranging
from approximately 6 A˚ diameter at the ‘‘entry’’ face side to
approximately 10 A˚ at the ‘‘exit’’ face side. One specific feature1668 Structure 23, 1665–1677, September 1, 2015 ª2015 Elsevier Ltof our LPHN3-OLF is the disordered 395–403 fragment, which
was also disordered in the LPHN3-RBL/OLF structure (Jackson
et al., 2015). A noticeable difference between LPHN3-OLF and
gliomedin-OLF consists in the presence in the central pore of a
Na+ atom instead of Ca2+ in the same position, showing that
different metal ions can be found at this site in OLF domains
(see below).
Comparison between the Two Crystal Forms
LPHN3-OLF crystallized in two lattices, P65 and C2221. The ma-
jor difference in the crystallization conditions was in the range of
concentration of MgCl2 used (either 50 mM for the P65 form or
300 mM for the C2221 form, see Experimental Procedures).
When superimposed, the structures refined from the two lattices
were very similar (root-mean-square deviation [rmsd] = 0.9 A˚,d All rights reserved
Figure 2. Crystal Structure of LPHN3-OLF in
P65 and C2221 Crystal Forms
(A) Cartoon representation of the overall folding
LPHN3-OLF, emphasizing its five-bladed b-pro-
peller folding. View from the ‘‘entry face’’ colored
in rainbow mode from blue (N terminus) to red
(C terminus). The Ca2+ ion, found in the central
channel of the b propeller, is represented in sphere
mode.
(B) Ca traces of the two superimposed LPHN3-
OLF structures in P65 and C2221 crystal forms.
The main structural differences are in the loops
316–329, 392–405, and 425–434 (red for the C2221
and blue for the P65 crystal form). The side chain
of Tyr323 is represented to highlight a core
stabilization of the loop 316–329 in the P65 form
(‘‘closed’’ conformation), versus the C2221 form
(‘‘open’’ conformation).
(C) Comparison between the atomic thermal
motions of the structure in both crystal forms along
the backbone: from blue and thin for the lowest
B-factor values to thick and red for the highest
ones. The coloring/thickness of these cartoon
representations is scaled in the range of 8.49
and 77.18 A˚2, the minimal and maximal values of B
factors from both models.
(D) Detailed views of the solvent-accessible sur-
face of cavities and pockets (cyan) in the P65 and
C2221 crystal forms, highlighting an accessibility of
the central pore in the C2221 form.
(E) Metal ion binding in the central pore of the
P65 and C2221 crystal forms and contoured with
the 2mFo-DFc electron density map. Both panels
summarize the protein residues and water mole-
cules (red spheres) involved in the octahedric
coordination of the observed Ca2+ (P65) or Mg
2+
(C2221). The relevant inter-atomic distances (A˚) are
reported (insets).
See also Figure S1.243 aligned Ca out of 254), with the exception of the loop 316–
329, which is stabilized by the protein core in the P65 lattice
(‘‘closed’’ conformation) and projects toward a symmetric
neighbor in the C2221 lattice (‘‘open’’ conformation) (Figure 2B).
In the open state, this loop is highly flexible, as illustrated by a
dramatic increase of its thermal motion (B factors) compared
with the rest of the protein and the closed conformation (Fig-
ure 2C). Indeed, the position of the loop in the open conformation
was weakly defined by the electron density maps. Accompa-
nying the movement of loop 316–329, two other neighboring
loops (392–405 and 425–434) undergo a noticeable conforma-
tional change (Figure 2B). Interestingly, loop 392–405 includes
the unmodeled fragment 397–403.
Consequent to the opening of the 316–329 loop (C2221), the
b-propeller central cleft becomes solvent accessible from the
‘‘entry’’ face (Figure 2D), with a total volume of accessible area
of 1,550 A˚3, as opposed to the value of the closed state (P65)Structure 23, 1665–1677, September 1, 2015of only 220 A˚3 of a buried cavity, discon-
nected from the surface of the protein.
By examining the geometric characteris-
tics of the coordination sphere of a het-
eroatom found in the central cleft, andexploiting the anomalous signal from the dataset collected at
low energy through an f00 refinement (Liu et al., 2013), we identi-
fied a Ca2+ in the closed state (Figure 2E). The shorter cation-ox-
ygen distances within the octahedric coordination geometry of
the open state (Figure 2E) clearly designate an Mg2+ ion (Har-
ding, 2006) also validated by CheckMyMetal (Zheng et al.,
2014). Hence, with the presence of 300 mM Mg2+ used in crys-
tallization, Ca2+ was replaced by Mg2+. In the closed state, the
Ca2+ bridges three central cleft b strands through the involve-
ment of residue atoms in its coordination: Asp332 Od2 (b10),
Asn380 Od1 (b14), and Val435 O (b18). In addition, the loop
316–329 is involved in the binding of the calcium ion via a
hydrogen bond between Tyr323 and Asp332. By contrast, the
Mg2+ ion found in open state is coordinated only by residues
from b18, Asp436 Od1, and Val435 O. Therefore, the opening
of loop 316–329 and the concomitant disruption of the hydrogen
bond between Tyr323 and Asp332 likely allows for a solventª2015 Elsevier Ltd All rights reserved 1669
Figure 3. DXMS Analysis Profiles of LPHN3-
OLF, Alone or Bound to FLRT3-LRR Domain
(A) Deuteration levels of the fragment 316–329 of
LPHN3-OLF domain alone.
(B) Schematics of the deuteration levels of loop
316–329 to indicate the deuteration over time.
(C) Deuteration level of loop 316–329 of LPHN3-
OLF in complex with FLRT3-LRR.
(D) Difference in deuteration level of loop 316–329
between the free and bound LPHN3-OLF domain.
For (A), (C), and (D), the percentages of deuteration
levels of each peptide fragment at various time
points are shown as a heatmap color coded
from blue (10%) to red (90%), as indicated at the
bottom of each map. Each block under the protein
sequence represents a peptide segment analyzed
at each of the four time points (from top to bottom:
10, 100, 1,000, and 10,000 s). Differential deuter-
ation is shown in a color-coded map ranging from
blue (50%) to red (+50%), as indicated at the
bottom of the panel. Proline residues and regions
with no amide hydrogen exchange data available
are colored in gray.
(E) Structure of the entire P65 LPHN3-OLF color
coded according to the differential deuteration
map. Cyan to dark-blue colors indicate increasing
protection of LPHN3-OLF in complex with
FLRT-LRR; orange indicates increased solvent
accessibility.
See also Figures S2 and S3.accessibility of the central pore, which resulted in a displace-
ment of the bound Ca2+ by Mg2+ at high concentration in the
crystallization liquor.
Themodel refinement of the P65 crystal form indicated that the
cation Ca2+-binding site was not fully occupied by the Ca2+,
which was refined with 70% occupancy. Although partial ex-
change of Ca2+ by Mg2+ could have occurred in the P65 form,
our crystallographic data are not sufficient to definitively
conclude which proportion of Ca2+/Mg2+ composes the mixture.
However, as the physiological concentration of Mg2+ in the
extracellular fluids is 0.7–1 mM (Bringhurst et al., 2012), the
presence of Mg2+ in the C2221 crystal structure is most likely a
crystallization artifact. Recently determined structures of myoci-
lin-OLF (Donegan et al., 2014) and LPHN3-RBL/OLF (Jackson
et al., 2015) contain the same Ca2+-binding site and an Na+ in
the central pore that we could not identify from the electron den-
sity maps, probably due to a partial occupancy, like Ca2+, as
indicated by the alternative conformation of Asp436 (P65) (Fig-
ures 2E and S1B). Hence, a joint analysis of the two crystal forms
of LPHN3-OLF and the LPHN3-RBL/OLF structure reveals that
Ca2+ and Na+ both contribute to the conformational stability of
the central pore residues, specifically Asp332 (Ca2+) and1670 Structure 23, 1665–1677, September 1, 2015 ª2015 Elsevier Ltd All rights reservedAsp436 (Na+). These ions also contribute
to a core stabilization of the loop 316–
329 through the Ca2+-Asp332-Tyr323
interaction network. However, the partial
occupancy of the ions in the P65 form
and the availability of the C2221
open state, where the Mg2+ occupancy
reached 100%, show that they are notabsolutely required for the maintenance of the overall folding of
LPHN3-OLF.
DXMS
To obtain dynamic information on the individual structures
and their complex, we used DXMS. After optimization of the
mass spectrometry (MS) coverage of the individual proteins
(data not shown), high-resolution MS data were collected
on LPHN3-OLF alone and bound to FLRT3-LRR. Deuteration
levels of LPHN3-OLF alone show that the first 20 amino
acids (APSTDHLDYKDDDDKAAAKV) and the last 40 amino
acids (LDSRSGPVHHGQVSYISPPIHLDSELERPPVRGILEVLFQ)
of the protein exchanged >90% deuteron in the first 10 s, indi-
cating that these regions are fully solvent exposed and disor-
dered. These 60 residues are clipped during crystallization
trials and could not be built in our structure. Interestingly,
among the LPHN3-OLF fragments that acquire deuteration
over time (see Supplemental Information; Figures S2 and S3;
Figure 3), loop 316–329 is gradually deuterated and acquires
>50% deuteration in 100 s, reaching 90% deuteration after
10,000 s (Figure 3A). This increase in deuteration level indi-
cates a progressive solvent exposure of the amide hydrogens.
Figure 4. Complex between LPHN3-OLF and FLRT3-LRR
(A) (Left) Side view of the surface rendering of the LPHN3-OLF/FLRT3-LRR
complex. Green, FLRT3-LRR; orange, LPHN3-OLF. The view highlights the
associating surfaces of the structure that is the N-terminal part of the concave
surface of FLRT3-LRR and the lack of contact on the C-terminal part of it.
(Right) Front view of the surface rendering of the complex to highlight the45
clockwise inclination of OLF through its central pore.
(B) ‘‘Open-book view’’ of the semi-transparent surface, highlighting both
ribbon diagram and side chains of the residues involved in the association and
the main secondary structural elements.
(C) Surface view of LPHN3-OLF (top) and FLRT3-LRR (bottom), highlighting
the relative sequence conservation of the binding surface. Blue indicates high
conservation and red indicates lowest conservation scores. Red ovals indicate
the same binding surface in the different orientations. LPHN3-OLFwas aligned
with 20 other OLF domains of latrophilins, and FLRT3-LRRwas aligned with 73
unique sequences from CSI-BLAST.In light of the crystallographic models, this strongly suggests
that loop 316–329 is dynamic, as a result of a conformational
motion between the closed and open state (Figure 3B). There-
fore, our experiments show a propensity of the OLF centralStructure 23, 1665–16pore to be filled by solvent molecules, driven by a movement
of loop 316–329.
Deuteration levels of LPHN3-OLF in complex with FLRT3-LRR
should reveal whether some of the loops belonging to the bind-
ing interface become more solvent protected. In fact, LPHN3-
OLF loop 316–329 in complex with FLRT3-LRR is significantly
less deuterated than in the free protein (Figures 3C and 3D).
These data suggest that loop 316–329 is stabilized in a sol-
vent-inaccessible area of the complex (see below). To a lesser
extent, fragment 396–400 also shows a high level of deuteration,
indicating a large degree of flexibility (>50% deuteration in
100 s), consistent with the absence of this loop in the crystallo-
graphic models (Figures S2A and S2B; Figure 3; Table S1; Fig-
ure 2). Other neighboring and superficial fragments show various
degrees of solvent protection (Phe217-Trp226; Met240-Thr247;
Asn289-Val297; Arg376-Met383; Tyr429-Ala433; Glu401-
Tyr409), whereas loops that are distant from the putative bind-
ing surface show higher deuteration exposure (Lys228-Ala233;
Thr303-Ala310) (Figure 3E), in agreement with the interfacing
area revealed by crystallography.
Crystal Structure of the LPHN3-OLF/FLRT3-LRR
Complex
We have determined the structure of the 1:1 LPHN3-OLF/
FLRT3-LRR complex at a resolution of 3.2 A˚. Overall, the com-
plex is assembled so that the concave face of the horseshoe-
shaped solenoid FLRT3-LRR interacts with LPHN3-OLF, and
the central pore axis of LPHN3-OLF is oriented 45 relative to
the FLRT3-LRR long axis (Figure 4A). The LPHN3-OLF structure
in complex with FLRT3-LRR enabled us to model four more res-
idues in a disordered loop (400-NEAT-403) and five at the C-ter-
minal end (463-DSRGP-467) not modeled in the free protein. The
FLRT3-LRR interfacing residues aremainly provided by its N-ter-
minal moiety and are part of the capping LRRNT and the first
eight LRR motifs (Figure 4B; Table S3). All three predicted
N-linked glycosylation sites of FLRT3-LRR are situated far from
the interface, and one N-acetyl-glucosamine moiety could be
modeled on Asn226. The LPHN3-OLF residues involved in the
association belong to b strands connecting loops projected by
blades I–III toward the same region of the tertiary structure
next to the ‘‘entry’’ face (Table S3; Figure 4B). The FLRT3-LRR
remaining repeats and the capping LRRCT show only few resi-
dues (Arg275, Gln299, Lys326, Asn328, and Arg330) partly
buried by the LPHN3-OLF fragment 261–267 (Table S3; Figure 4).
The calculated total solvent-accessible area buried in the inter-
face is 867 A˚2, and this interface was computationally assigned
as biologically relevant by the EPPIC server (data not shown).
To obtain better insight into the specificity of interaction, we
mapped the surface of the two proteins according to their con-
servation score from the ConSurf server (Ashkenazy et al.,
2010) (Figure 4C) using 73 LRR and 20 LPHN-OLF unique se-
quences. The analysis indicates that interfacing areas of both
proteins are mainly composed of residues with high conserva-
tion scores. Interestingly, another highly conserved area prox-
imal to the LPHN3-OLF/FLRT3-LRR interface was observed in
both proteins (Figure 4C). In FLRT3-LRR this area matches the
Unc5D/FLRT2 complex interface (Seiradake et al., 2014).
Mapping the electrostatic surface of the two proteins provides
evidence on the observed binding mode: a cluster of negatively77, September 1, 2015 ª2015 Elsevier Ltd All rights reserved 1671
Figure 5. Analyses of the LPHN3-OLF/FLRT3-LRR Association
(A) Electrostatic surface of LPHN3-OLF and FLRT3-LRR in open-book view to emphasize a charge complementarity within the main interfacing area of both
partners (green oval) and a repulsive facing area (orange square).
(B) Stereo view of the stabilization of the LPHN3-OLF loop 316–329 in the complex. Interfacing LPHN3-OLF and FLRT3-LRR residues are represented in yellow
and cyan, respectively, and the potential hydrogen bonds are shown as dashed magenta lines. Loop 316–329 (closed conformation) with the Tyr323 and Asp332
(legend continued on next page)
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charged residues formed by Asp113, Asp136, Asp137, and
Asp183 in FLRT3-LRR complements the positively charged
Arg273, Arg292, Arg294, and in LPHN3-OLF (Figure 5A). More-
over, several hydrogen bonds and salt bridges are observed in
the main interface (Table S3; Figure 4) added by hydrophobic
and stacking contacts involving aromatic side chains, such as
Phe160 from FLRT3-LRR observed in a p-stacking with Tyr245
from LPHN3-OLF (see below). Conversely, the C-terminal region
of the concave face in FLRT3-LRR and the facing area in LPHN3-
OLF do not seem to be in contact, probably because they are
both positively charged and likely to repel each other (Figure 5A).
Within the complex, the LPHN3-OLF flexible 316–329 loop
is stabilized in the closed state, via direct interactions with
FLRT3-LRR established by Asn316, Tyr317, Asp319, and
Thr320. The mobility of the entire loop is further restrained by
the interfacing interactions established by Arg376 with Tyr43
and Tyr64 in FLRT3-LRR, which maintains the b13-b14 connect-
ing loop on top of the 316–329 loop, and contributes to lock its
conformation (Figures 5B and 5C).
We next determined whether the association requires a signif-
icant conformational change of either of the two proteins, or
whether it is of rigid-body type. Superimposition of the LPHN3-
OLF subunit with the P65 Ca
2+-bound structure reveals an
rmsd of 0.56 A˚ over 256 aligned Ca. The same procedure
made with the FLRT3-LRR subunit with the recently determined
structure (PDB: 4V2E) (Seiradake et al., 2014) gives an overall
rmsd of 1.20 A˚ for 321 aligned Ca, a value that falls to 0.96 A˚
when aligning the first 219 Ca (residues 30–248), which contain
the main interfacing residues described earlier. This comparison
indicates that the structures of LPHN3-OLF and FLRT3-LRR are
rigid and undergo a rigid-body type interaction without any sig-
nificant rearrangements, providing that the LPHN3-OLF is in
the closed state.
Mutational Analysis of the Association
To test how the stabilization of the 316–329 loop affects
the LPHN3-OLF/FLRT3-LRR association, we engineered an
Asp332Ala and a Tyr323Ala that should disrupt the Ca2+-driven
stabilization of this loop, and measured their interaction with
FLRT3-LRR. All mutant proteins were first analyzed by SEC to
reveal potential misfolding or oligomerization state abnormal-
ities. As expected, the expression level of all mutants and their
elution profile were identical to the ones measured for the wild-
type proteins (data not shown). The mutant Asp332Ala showed
a decreased affinity (KD 170 nM) (Table 1), indicating that
Asp332 is important by strengthening the closed state through
the coordination of Ca2+ and the Asp332-Tyr323 hydrogen
bond. Furthermore, the mutant Tyr323Ala showed no detectableresidues and Ca2+ are shown in purple. The central pore b strands b10, b14, and b
of the 316–329 loop are also shown in orange.
(C) Loop 316–329 in the open state (C2221) of LPHN3-OLF from a superimpositio
surfaces of the residues that would display a steric clash.
(D–H) Analyses of the binding between LPHN3-OLF/FLRT3-LRR by site-directed
mutations. (E) Western blot showing the FLRT3-LRR mutants used in this figure a
experimental trace of the LPHN3-OLF injected at 100 mM into the cell containing th
LPHN3-OLF injected at 100 mM into the cell containing the FLRT3-LRR F160N m
OLF binding surface that prevents the association. (H) ITC experimental trace of th
mutant at 10 mM.
Structure 23, 1665–16binding in conditions similar to those for the wild-type measure-
ments, which strongly suggests that Tyr323 is key to maintaining
the closed state. Moreover, to confirm the binding mode be-
tween LPHN3-OLF and FLRT3-LRR revealed by the crystallo-
graphic study, an N-linked glycosylation site was introduced in
the FLRT3-LRR interfacing surface and compared with a glyco-
sylated mutant outside of the binding interface. At the interfacing
position 160 we substituted Phe160with an Asn, to complete the
canonical Nx(S/T) sequon. As a control mutant, the surface res-
idue Asn115 was glycosylated by substituting Arg117 to a Thr
(Table 1). The additional N-linked glycosylation was verified by
SDS-PAGE, showing slower migrating bands for the Phe160Asn
and Arg117Thr mutants compared with the Phe160Ala or the
wild-type construct (Figures 5D and 5E; Table 1). The glycosy-
lated Arg117Thr mutant had a measured KD of 27 nM, typical
of wild-type values (Figure 5F; Table 1). In contrast, Phe160Asn
mutant showed no detectable binding in similar conditions
(Figure 5G; Table 1), indicating that introducing bulky sugar
moieties in the interface observed in the crystal structure
severely affected the LPHN3-OLF/FLRT3-LRR association. As
the Phe160 side chain was found to establish a direct interaction
with the LPHN3-OLF Tyr245 in the complex structure, an Ala
mutant was also designed to obtain insight into the importance
of this specific position for the affinity between the two partners.
For the Phe160Ala mutant a KD of 1 mM was determined, sug-
gesting that Phe160 is a key residue in the association and that
the contact this residue establishes with LPHN3-OLF Tyr245 is
likely to be of major importance (Figure 5H; Table 1).
Finally, we analyzed the LPHN3-OLF mutation Ala313Ser re-
ported in an ADHD patient (Domene et al., 2011). The mutant
protein is expressed at levels similar to those of the wild-type
protein, and both hydrodynamic parameters and association
with FLRT3-LRR were similar to those of the wild-type protein
(Table 1). These data indicate that Ala313, which is situated at
a surface region distinct from the complex interface (12 A˚
from the closest FLRT3-LRR residue), does not play an important
role in the association with FRLT3-LRR.
DISCUSSION
We previously reported that LPHN3 binds in vivo and in vitro to
FLRT3 to constitute a synaptic ligand-receptor pair (O’Sullivan
et al., 2012). Single-particle electron microscopy of LPHN3
showed that its entire extracellular domain is organized into
two globular regions separated by a semi-rigid domain that is
O-linked glycosylated (O’Sullivan et al., 2014). However, these
studies did not allow a detailed structural and functional charac-
terization of the minimal domain necessary for the interaction18 involved in the Ca2+ binding and the b13-b14 connecting loop that lies on top
n with the complex structure. Red and green meshes represent the molecular
mutagenesis on FLRT3-LRR. (D) Models showing the overall position of the
nd their different migration pattern due to the additional glycosylation. (F) ITC
e FLRT3-LRR R117T control mutant at 10 mM. (G) ITC experimental trace of the
utant at 10 mM. This mutant has an additional N-linked glycosylation site at the
e LPHN3-OLF injected at 100 mM into the cell containing the FLRT3-LRR F160A
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with FLRT3. Here, we show that only the OLF domain of LPHN3
is required for FLRT3-LRR binding, and we determined precise
dissociation constants and stoichiometry of the complex. As ex-
pected, the KD measured for this interaction (Table 1) are similar
to that determined for their entire extracellular domains (O’Sulli-
van et al., 2012), indicating that LPHN3-OLF alone is sufficient to
bind FLRT3-LRR.
Characterization of the Olfactomedin Domain Structure
Initial diffraction data were not sufficient to obtain a structure
solution by molecular replacement approaches, most likely
because at the time of our data analysis the closest five-bladed
b-propeller homolog available had less than 13% amino acid
identity to our protein. Therefore, we successfully resorted to
multi-crystal native SAD phasing (Liu et al., 2012), illustrating
the robustness of using anomalous signal from light atoms
such as sulfur for structure determination. Furthermore, we
show how such signals can be critical in ascertaining the nature
of anomalous scatterers through the characteristic imaginary
terms of their scattering factor (f00); the bound Ca2+ (P65) or
Mg2+ (C2221) in our case. The crystal structure of the LPHN3-
OLF shows that this domain has a five-bladed b-propeller fold
that is monomeric in solution. Despite the broad structural
diversity of the b-propeller architecture, two features are often
conserved among members of this fold: the four-stranded anti-
parallel b sheets and the central pore where metal ions might
also bind, further stabilizing the structure (Chen et al., 2011).
Loop 316–329 Mobility
In LPHN3-OLF, our crystallographic study designates loop 316–
329 as one of the structural elements stabilized in presence of
Ca2+ (the closed state), indirectly via a hydrogen bond between
Asp332 and Tyr323.Moreover, this loop is involved in the binding
interface with FLRT3-LRR as also shown by DXMS, and in fact
the open state of this loop is incompatible with the binding to
FLRT3-LRR. However, loop 316–329 was found to be dynamic
both in cristallo and in solution, as shown by DXMS of LPHN3-
OLF alone (Figure 3A), which allows solvent exchange in the
b-propeller central pore, evidenced by the C2221 crystal form.
The high concentration of Mg2+ used for the crystallization of
the C2221 crystal form led to a complete Ca
2+/Mg2+ exchange
in the central pore and to a stable enough conformation to be
crystallized. Due to the well-established specific (de-)hydration
properties of the Mg2+ ion compared with Ca2+ (Maguire and
Cowan, 2002), the ion coordination with Asp332 probably could
not be established, maintaining loop 316–319 in an open state.
Although loop 316–329 is dynamic under physiological condi-
tions, a Ca2+/Mg2+ exchange may rarely occur in vivo due to
the relatively low concentration and the balance of these two
ions in the extracellular fluids. These observations confer to the
presence of Ca2+ in the central pore an important, albeit indirect,
role in the complex formation.
Some conformational motion of the myocilin-OLF equivalent
loop B-10/C-11 has been reported when comparing the poly-
ethylene glycol-containing wild-type structure with the glyc-
erol-containing form or with the SeMet derivative form of the
E396D mutant (Donegan et al., 2014). Gliomedin-OLF appears
to be different in this respect, since the LPHN3-OLF Tyr323-
Asp332-Ca2+ trio structurally superimposes with Phe415-1674 Structure 23, 1665–1677, September 1, 2015 ª2015 Elsevier LtAsn423-Na+ (Figures S1D and 2); however, the gliomedin-OLF
407–420 loop (equivalent to LPHN3-OLF 316–329) is poorly
conserved (Han and Kursula, 2015). The fact that Phe415 and
the proximal Leu414 are involved in a core-buried hydrophobic
cluster suggests that the entire loop is less dynamic. In general,
solvent accessibility of the OLF b-propeller central cavity ap-
pears to be a shared feature, as exhibited by the presence of
a high density of bound water molecules in the available struc-
tures of OLF domains (Donegan et al., 2014; Han and Kursula,
2015; Jackson et al., 2015; Pronker et al., 2015; this study).
Furthermore, most of the Ca2+-binding residues in LPHN3-
OLF are conserved, or conservatively substituted, in the OLF
family, in particular those having their side chain involved
in the ion coordination. Although our open-state structure
was solved with a higher than physiological amount of Mg2+,
gliomedin-OLF (Han and Kursula, 2015) was crystallized with a
subphysiological amount of Na+, indicating that Na+ likely ex-
changes in vivo.
The LPHN3-OLF/FLRT3-LRR Complex
There is ample experimental evidence that LRR proteins tend to
form quaternary structures with dimerization or multimerization
surfaces (Scott et al., 2004; Seiradake et al., 2014). Although
it is unclear whether these quaternary complexes are able
to dissociate upon ligand binding (McEwan et al., 2006), our
FLRT3-LRR/LPHN3-OLF complex is monomeric in solution,
indicating that the tendency of FLRT3 to self-associate under
concentrated condition (Figures 1D and 1E; Seiradake et al.,
2014) is reversed upon binding with LPHN3-OLF. The curved
structure of the LRR domain and the exposed b sheet on the
concave side form a large binding surface, which makes the
LRR domain a very effective protein-binding motif (Kobe and Ka-
java, 2001). Although ligand binding through concave surfaces
of LRR domains is common, it is not exclusive: for example,
UNC5D binds to one side of FLRT2 (Seiradake et al., 2014). It
is worth noting that the LRR-OLF interface area appears rela-
tively small with respect to the high affinity of the interaction
(Chen et al., 2013). Therefore, beyond the solvent inaccessibility
of interface residues, some key structural features, such as
the strong electrostatic surface complementary between the
concave face of FLRT3-LRR and globular LPHN3-OLF, are at
play in the stability of the OLF-LRR association. Our mutational
analyses point to the FLRT3-LRR Phe160. Indeed, its central po-
sition within the interface, its high level of buried area (Table S3;
Figure 4), and the observed affinity decrease in Phe160Ala make
this position ‘‘hot spot’’ for the interaction (Bogan and Thorn,
1998). Regarding the ADHD-linked mutation, this residue is not
conserved in the LPHN family and the Ala313 Ser mutation
does not affect FLRT3 binding, suggesting that it may simply
represent a benign SNP.
Taken together, an overall association model emerges from
our studies. In the unbound state, the LRR motif of FLRT3 can
dimerize with low affinity (40 mM) and LPHN3-OLF loop 316–
329 is dynamic in the timescale seconds to minutes. Once these
domains associate, there would be strong stabilization of the
LPHN3-OLF domain in the close conformation and the disrup-
tion of the FLRT3 dimerization toward a high-affinity LPHN3-
OLF/FLRT3-LRR complex (Figure 6A). LPHN3 is a presynaptic
protein containing an OLF domain which, through the centrald All rights reserved
Figure 6. Overall Model of the Association in the Context of the
Synapse
(A) FLRT-LRR alone tends to weakly dimerize, and LPHN3-OLF alone has loop
316–329 that is mobile, possibly allowing and Ca2+ and Na+ exchange. The
high affinity of the associationmaintains LPHN3-OLF loop 316–329 closed and
dissociates the low-affinity homodimerization of FLRT3-LRR.
(B) LPHN3 is presynaptic and binds through the OLF domain to the LRR
domain of FLRT3, a post-synaptic protein. With the exception of the central
O-linked glycosylated stalk domain drawn between the GAIN domain and the
OLF domain, the rest of extracellular domain of LPHN3 has been determined
using crystallography. FLRT3 FN3 domain is represented as a homology
model using other FN3 domains as template. Approximate dimensions are
shown in angstroms (A˚).O-linked glycosylated domain the OLF domain, can reach the
LRR of post-synaptic FLRT3 across the synaptic cleft, where
they can interact (Figure 6B) (O’Sullivan et al., 2014).Structure 23, 1665–16It was recently reported that LPHN3-OLF also binds FLRT2
with low-nanomolar affinity and that neurons were repelled by
the presence of LPHN3-OLF in the growth matrix of a stripe
assay (Jackson et al., 2015). Moreover, overlay of the coordi-
nates of the published mouse FLRT2-LRR in complex with the
first immunoglobulin (Ig) domain of UNC5D (PDB: 4V2C) (Seira-
dake et al., 2014) with our complex suggest that a trimeric com-
plex composed of FLRT2 or FLRT3-LRR/LPHN 3-OLF/UNC5D-
Ig1 is possible. Owing to this intricate recognition code between
FLRTs and LPHN3, which may generate adhesion or repulsion,
the structural characterization of the presented complex will be
important to inform testable mechanistic-based hypotheses in
the biology of synapse formation and in vivo axonal attraction
and repulsion.
EXPERIMENTAL PROCEDURES
Cloning and Expression of FLRT3 and LPHN3
The extracellular domains of mouse LPHN3 and mouse FLRT3 and their
shorter constructs were cloned as C-terminal Fc-fusion proteins into a modi-
fied pCMV6-XL4 plasmid and were expressed as soluble entities in the cell
culture medium of stably transfected HEK293 GNTI cells, and maintained
in 10% fetal bovine serum in DMEM.
Protein Purification
Proteins were affinity purified using Protein-A resin using in 50 mM Tris-HCl
(pH 7.4), 150 mM NaCl, 1 mM EDTA (TNE), and subsequently cleaved with
3C protease to remove the Fc fragment. Proteins were further purified by
SEC in 50 mM Tris-HCl (pH 7.4) and 150 mM NaCl (TN), and concentrated
depending on the downstream experiment.
ITC
Experiments were performed with a MicroCaliTC200 system, and purified pro-
teins were buffer-exchanged in 50 mM Na-HEPES (pH 7.0), 150 mM NaCl,
1 mM EDTA (or 2 mM CaCl2). The protein solution in the syringe was added
to the cell in a series of multiple injections at 25C. The raw ITC data were pro-
cessed and fitted using a single-site model using ORIGIN software provided by
GE MicroCal.
AUC
AUC was performed on a Beckman Optima XL-I analytical ultracentrifuge. All
samples were measured at 35 krpm and scanned at 281 nm, and data were
acquired in intensity mode. All samples were measured in a buffer containing
50 mM Tris-HCl (pH 7.4), 150 mM NaCl, and 1 mM EDTA. Data were analyzed
with UltraScan-III v.3.1, release 1964.
Protein Crystallography
Crystals of LPHN3-OLFwere made by under-oil microbatchmethod bymixing
1 ml of protein with an equal volume of crystallization solution containing [15–
25]% polyethylene glycol 8000, [50–300] mM MgCl2, and 0.1 M TAPS buffer
(pH 9.0). C2221 crystal forms were harvested from 50 mM MgCl2-containing
conditions, whereas P65 crystal forms grew in 300 mMMgCl2-containing con-
ditions. Crystals of the complex were prepared by vapor diffusion in hanging
drops by mixing 1 ml of a 1:1.2 molar ratio mixture of LPHN3-OLF and
FLRT3-LRR with an equal volume of crystallization solution containing 6%
polyethylene glycol 3350 and 0.2MNaNO3. Complete datasets were collected
from individual crystals under a cryogenic stream at 100 K. All diffraction data-
sets were processed by XDS and SCALA. For the LPHN3-OLF structure,
native SAD phasing was performed first by substructure solution with SHELXD
and subsequent SAD phasing with PHENIX module PHASER, using four
diffraction datasets collected with a 6-keV X-ray beam. The subsequent
2.6-A˚ resolution initial model was further refined using phenix.refine against
separated collected P65 and C2221 data at 1.6 A˚ resolution, after a molecular
replacement with the PHENIX module PHASER for the latter. The complex
structure was solved by molecular replacement using the PHENIX module77, September 1, 2015 ª2015 Elsevier Ltd All rights reserved 1675
PHASER using the P65 structure of LPHN3-OLF and the recently determined
structure of FLRT3-LRR (PDB: 4V2E) as starting models. Subsequent refine-
ment of the structure was performed using BUSTER.
DXMS
Comparative deuterium-exchange MS studies were carried out with LPHN3-
OLF alone and with LPHN3-OLF/FLRT3 complex by mixing these proteins at
1:1 molar ratio. The exchange reactions were quenched at various time points
by addition of 18 ml of ice-cold 0.8% formic acid, 0.8 M GuHCl, and 16.6%
glycerol for a final pH of 2.5. Peptide identificationwas donewith the aid of Pro-
teome Discoverer software (ThermoFisher).
More details can be found in the Supplemental Procedure.
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The atomic coordinates and associated structure factors were deposited un-
der the accession codes PDB: 4RMK (P65) and 4RML (C2221) for the LPHN3-
OLF structures, and PDB: 4YEB for the LPHN3-OLF/FLRT3-LRR complex
structure.
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